NCT05956834Active, not recruiting
A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration (FTLD) Syndromes
Source: ClinicalTrials.gov · Last updated 21 Jan 2026
Brief summary (registry, in English)
The primary objective of this study is to enroll an observational cohort of approximately 60 patients with PSP over the course of 24 months using a multicenter study design and to follow each of them for 12 months. The secondary objective of this study is to develop a robust solution for multi-modal remote monitoring of motor symptoms and function in PSP that can be applied to other Frontotemporal lobar degeneration (FTLD) syndromes.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 60 (estimated)
- First submitted
- 14 Jul 2023
- Start date
- 28 Jul 2023
- Primary completion date
- 30 Jun 2026
- Lead sponsor
- Massachusetts General Hospital
- Diseases
- Frontotemporal dementia
- NCT number
- NCT05956834
What you commit to
- Study type: Observational
- Planned participants: 60
- From 28 Jul 2023 to the primary completion date, 30 Jun 2026
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Any neurological, medical, or psychiatric condition that would preclude participation in study activities based on the investigator's judgment.
- A history of frequent falls defined as more than 5 falls per month, or who require a walker to ambulate safely at baseline will not be eligible to participate in the study.
Who the study is looking for
- Clinical diagnosis of possible or probable PSP as defined by the 2017 MDS criteria
- Fluent in reading and speaking English and capable of providing informed consent based on the principal investigator's judgement
- Able to walk 10 feet unassisted at the time of initial enrollment
- Must have a caregiver or study partner who is willing and able to assist with all study-related procedures
Age in the registry: 40 years to 89 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Johns Hopkins School of Medicine Coordinator of this site? Confirm its status | Baltimore | United States | Unknown status |
| Massachusetts General Hospital Coordinator of this site? Confirm its status | Boston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.